Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
Conditions
Irritable Bowel Syndrome (IBS) · Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University Hospitals Leuven (UZ Leuven), Leuven, Belgium
Contact: Study coordinator (Jan Tack)Hôpital Avicenne, Bobigny, France
Contact: Study coordinator (Jean Marc Sabaté)CHU de Rouen, Rouen, France
Contact: Study coordinator (Chloè Melchior)IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola, Bologna, BO, Italy
Contact: Study coordinator (Giovanni Barbara)IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milan, Italy
Contact: Study coordinator (Maurizio Vecchi)AOU Federico II di Napoli, Naples, Italy
Contact: Study coordinator (Giovanni Sarnelli)Azienda Ospedale Università Padova, Padova, Italy
Contact: Study coordinator (Edoardo Vincenzo Savarino)Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Contact: Study coordinator (Michele Di Stefano)Azienda Ospedaliero Universitaria Pisana (AOUP), Pisa, Italy
Contact: Study coordinator (Massimo Bellini)S. Andrea University Hospital, Roma, Italy
Contact: Study coordinator (Bruno Annibale)Hospital Universitario Vall d´Hebron, Barcelona, Spain
Contact: Study coordinator (Javier Santos)Hospital Universitario Ramón y Cajal, Madrid, Spain
Contact: Study coordinator (Carlos Teruel Sanchez-Vegazo)